UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 58 filers reported holding UNITY BIOTECHNOLOGY INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $11,000 | +120.0% | 29,974 | +207.4% | 0.00% | – |
| Q2 2022 | $5,000 | -77.3% | 9,750 | -50.5% | 0.00% | – |
| Q1 2022 | $22,000 | -83.5% | 19,706 | -78.4% | 0.00% | – |
| Q4 2021 | $133,000 | – | 91,345 | +3178.7% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 2,786 | +1439.2% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 181 | -23.6% | 0.00% | – |
| Q4 2019 | $1,000 | – | 237 | +113.5% | 0.00% | – |
| Q1 2019 | $0 | – | 111 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mayo Clinic | 1,571,981 | $7,294,000 | 8.07% |
| Invus Financial Advisors, LLC | 1,094,998 | $5,081,000 | 1.01% |
| Founders Fund V Management, LLC | 491,751 | $2,282,000 | 0.78% |
| Tibra Equities Europe Ltd | 80,700 | $374,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 205,882 | $955,000 | 0.11% |
| Hall Private Wealth Advisors | 18,500 | $86,000 | 0.06% |
| 20/20 Capital Management, Inc. | 42,840 | $199,000 | 0.05% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 64,789 | $301,000 | 0.05% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 759,918 | $3,526,000 | 0.02% |
| PDT Partners, LLC | 74,178 | $344,000 | 0.02% |